Parallel synthesis of an amide library based on the 6,8-dioxa-3- azabicyclo[3.2.1]octane scaffold by direct aminolysis of methyl esters

Journal of Combinatorial Chemistry

Volumn 9, Issue 3, 2007, Pages 454-461

  Machetti, Fabrizio ^a   Bucelli, Ilaria ^a   Indiani, Giovanni ^a   Kappe, C Oliver ^b   Guarna, Antonio ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF GRAZ   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

AMIDE; ESTER; FUSED HETEROCYCLIC RINGS;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; COMBINATORIAL CHEMISTRY; METHODOLOGY; STEREOISOMERISM; SYNTHESIS;

AMIDES; BICYCLO COMPOUNDS, HETEROCYCLIC; COMBINATORIAL CHEMISTRY TECHNIQUES; ESTERS; MOLECULAR STRUCTURE; STEREOISOMERISM;

EID: 34249943025     PISSN: 15204766     EISSN: None     Source Type: Journal    
DOI: 10.1021/cc060120o     Document Type: Article

References (86)

1. For recent selected examples of libraries built around a scaffold, see: (a) Nieto, M. J.; Philip, A. E.; Poupaert, J. H.; McCurdy, C. R. J. Comb. Chem. 2005, 7, 258-263.
2. (b) Rosania, G. R.; Lee, W. J.; Ding, L.; Yoon, H.-S.; Chang, Y.-T. J. Am. Chem. Soc. 2003, 125, 1130-1131.
3. (c) Holland, R. J.; Hardcastle, I. R.; Dick, A. G.; Nutley, B. P.; Hayes, A.; Jarman, M. Tetrahedron Lett. 2002, 43, 719-721.
4. (d) Ding, S.; Gray, N. S.; Wu, X.; Ding, Q.; Schultz, P. G. J. Am. Chem. Soc. 2002, 124, 1594-1596.
5. (e) Guan, Y.; Green, M. A.; Bergstrom, D. E. J. Comb. Chem. 2000, 2, 297-300.
6. (f) Organ, M. G.; Mayhew, D.; Cooper, J. T.; Dixon, C. E.; Lavorato, D. J.; Kaldor, S. W.; Siegel, M. G. J. Comb. Chem. 2001, 3, 64-67.
7. (g) Nilsson, J. W.; Thorstensson, F.; Kvarnstrom, I.; Oprea, T.; Samuelsson, B.; Nilsson, I. J. Comb. Chem. 2001, 3, 546-553.
8. (h) Hirschmann, R.; Ducry, L.; Smith, A. B., III. J. Org. Chem. 2000, 65, 8307-8316.
9. (i) Falorni, M.; Giacomelli, G.; Porcheddu, A.; Taddei, M. Eur. J. Org. Chem. 2000, 1669-1675.
10. (j) Couladouros, E. A.; Strongilos, A. T. Angew. Chem., Int. Ed. 2002, 41, 3677-3680.
11. (j) Gan, Z.; Reddy, P. T.; Quevillon, S.; CouveBonnaire, S.; Arya, Angew. Chem., Int. Ed. 2005, 44, 1366-1368.
12. (k) Farooq Biabani, M. A.; Grover, R. K.; Singh, S. K.; Kumar, S.; Raj, K.; Roy, R.; Kundu, B. Tetrahedron Lett. 2001, 42, 7119-7121.
13. (l) Rosenbohm, C.; Vanden Berghe, D.; Vlietinck, A.; Wengel, J. Tetrahedron 2001, 57, 6277-6287.
14. (m) Jain, R.; Kamau, M.; Wang, C.; Ippolito, R.; Wang, H.; Dulina, R.; Anderson, J.; Gange, D.; Sofia, M. J. Bioorg. Med. Chem. Lett. 2003, 13, 2185-2189.
15. (a) For natural-product-like scaffolds, see: Boldi, A. M. Curr. Opin. Chem. Biol. 2004, 8, 281-286.
16. (b) For dihydropyrimidine scaffolds, see: Dallinger, D.; Kappe, C. O. Pure Appl. Chem. 2005, 77, 155-161.
17. (c) For carbohydrate scaffolds, see: Ohnsmann, J.; Madalinski, M.; Kunz, H. Chim. Oggi 2005, 23, 20-23;
18. Le, G. T.; Abbenante, G.; Becker, B.; Grathwohl, M.; Halliday, J.; Tometzki, G.; Zuegg, J.; Meutermans, W. Drug Discovery Today 2003, 8, 701-709.
19. (d) For 1,3,5-triazine scaffolds, see: Giacomelli, G.; Porcheddu, A.; De Luca, L. Curr. Org. Chem. 2004, 8, 1497-1519.
20. (e) For diketopiperazine scaffolds, see: Fischer, Peter M. J. Pept. Sci. 2003, 9, 9-35.
21. For a detailed explanation of BTAa nomenclature, see ref 4.
22. Guarna, A.; Guidi, A.; Machetti, F.; Menchi, G.; Occhiato, E. G.; Scarpi, D.; Sisi, S.; Trabocchi, A. J. Org. Chem. 1999, 64, 7347-7364.
23. Guarna, A.; Occhiato, E. G.; Menchi, G.; Machetti, F. PCT Int. Appl. WO 01 64686, September 7, 2001.
24. Guarna, A.; Bucelli, I.; Machetti, F.; Menchi, G.; Occhiato, E. G.; Scarpi, D.; Trabocchi, A. Tetrahedron 2002, 55, 9865-9870.
25. Trabocchi, A.; Menchi, G.; Rolla, M.; Machetti, F.; Bucelli, I.; Guarna, A. Tetrahedron 2003, 59, 5251-5258.
26. Trabocchi, A.; Menchi, G.; Guarna, F.; Machetti, F.; Scarpi, D.; Guarna, A. Synlett 2006, 331-353.
27. Machetti, F.; Ferrali, A.; Menchi, G.; Guarna. A. Org. Lett. 2000, 2, 3987-3990.
28. North, M. Contemp. Org. Synth. 1994, 1, 475.
29. Beckwith, A. L. J. In The Chemistry of Amides: Synthesis of Amides; Zabicky, J., Ed.; Interscience: New York, 1970; p 96.
30. Hudson, D. J. Org. Chem. 1988, 53, 617-624.
31. Negwer, M.; Scharnow, H.-G. In Organic Chemical Drugs and their Synonymous, 8th ed; Wiley VCH: Weinheim, Germany, 2001; p 4254.
32. CRC Handbook of Pesticides; Milne, G. W. A., Ed.; CRC Press: Boca Raton, FL, 1994.
33. For a statistical investigation into the structural complementarity of natural products and synthetic compounds, see: Henkel, T.; Brunne, R. M.; Müller, H.; Reichel, F. Angew. Chem., Int. Ed. 1999, 38, 643-647.
34. Bohacek, R. S.; Shakespeare, W. C. In The Amide Linkage: Structural Significance in Chemistry, Biochemistry, and Materials Science; Greenberg, A., Breneman, C. M., Liebman, J. F., Eds.; Wiley: New York, 2000; Chapter 12.
35. For recent report on amide activity, see: (a) Antitumor. Rauko, P.; Novotny, L.; Dovinova, I.; Hunakova, L.; Szekeres, T.; Jayaram, H. N. Eur. J. Pharm. Sci. 2001, 12, 387-394.
36. (b) Anticonvulsant. Sobol, E.; Bialer, M.; Yagen, B. J. Med. Chem. 2004, 47, 4316-4326.
37. (c) Antimicrobial. Sener, E. A.; Bingöl, K. K.; Ören, Ì.; Arpaci, Ö. T.; Yalçin, I.; Altanlar, N. Il Farmaco 2000, 55, 469-476.
38. (d) Appendino, G.; Minassi, A.; Berton, L.; Moriello, A. S.; Cascio, M. G.; De Petrocellis, L., Di Marzo, V. J. Med. Chem. 2006, 49, 2333-2338.
39. (e) Antiestrogens. Han, Y.; Giroux, A.; Colucci, J.; Bayly, C. I.; Mckay, D. J.; Roy, S.; Xanthoudakis, S.; Vaillancourt, J.; Rasper, D. M.; Tam J.; Nicholson, D. W.; Zamboni, R. J. Biorg. Med. Chem. Lett. 2005, 15, 1173-1180.
40. (f) Janjic, J. M.; Mu, Y.; Kendall, C.; Stephenson, C. R. J.; Balachandran, R.; Raccor, B. S.; Lu, Y.; Zhu, G.; Xie, W.; Wipf, P.; Day, B. W. Bioorg. Med. Chem. 2005, 13, 157-164.
41. (f) HIV reverse transcriptase inhibitors. Behforouz, M.; Cai, W.; Stocksdale, M. G.; Lucas, J. S.; Jung, J. Y.; Briere, D.; Wang, A.; Katen, K. S.; Behforouz, N. C. J. Med. Chem. 2003, 46, 5773-5780.
42. (g) Cannabinoid analogues. Francisco, M. E. Y.; Seltzman, H. H.; Gilliam, A. F.; Mitchell, R. A.; Rider, S. L.; Pertwee, R. G.; Stevenson, L. A.; Thomas, B. F. J. Med. Chem. 2002, 45, 2708-2719.
43. (h) Neuraminidase inhibitors. Chand, P.; Sudhakar, B. Y.; Bantia, S.; Rowland, S.; Dehghani, A.; Kotian, P. L.; Hutchison, T. L.; Ali, S.; Brouillette,W.; ElKattan, Y.; Lin, T.-H. J. Med. Chem. 2004, 47, 1919-1929.
44. (i) CCR5 receptor antagonists. Palani, A.; Shapiro, S.; Josien, H.; Bara, T.; Clader, J. W.; Greenlee, W. J.; Cox, K.; Strizzi, J. M.; Baroudy B. M. J. Med. Chem. 2002, 45, 3143-3 160.
45. (j) 5-HT1F receptor agonists. Filla, S. A.; Mathes, B. M.; Johnson, K. W.; Phebus, L. A.; Cohen, M. L.; Nelson, D. L. Zgombick, J. M.; Erickson, J. A.; Schenck, K.W.; Wainscott, D. B.; Branchek, T. A.; Schaus, J. M. J. Med. Chem. 2003, 46, 3060-3071.
46. (k) Hypolipidemic activity. Hernández, D.; Bernai, P.; Cruz, A.; Garciafigueroa, Y.; Garduño, L.; Salazar, M.; Díaz, F.; Chamorro, G.; Tamariz, J. Drug Dev. Res. 2004, 61, 19-36.
47. Antiproliferative activity against prostate cancer. Gududuru, V.; Hurh, E.; Dalton, J. T.; Miller, D. D. Biorg. Med. Chem. Lett. 2004, 14, 5289-5293.
48. (a) For insecticidal properties, see: Siddiqui, B. S.; Gulzae, T.; Begun, S.; Rasheed, M.; Sattar, F. A. Helv. Chim. Acta 2003, 86, 2760-2767.
49. (b) Siddiqui, B. S.; Gulzae, T.; Begun, S.; Afshan, F.; Sattar. F. A. Helv. Chim. Acta 2004, 87, 660-666.
50. See ref 10 in Brown, A. R.; Rees, D. C.; Rankovic, Z.; Morphy, J. R. J. Am. Chem. Soc. 1997, 119, 3288-3295.
51. Beckwith, A. L. J. In The Chemistry of Amides; Zabicky, J., Ed.; Wiley-Interscience: New York, 1970; pp 96-109.
52. For the application of specific active esters such as 4-nitrophenyl or pentafluorophenyl, respectively, see: a) Bodanszky, M. Nature, 1955, 775, 685.
53. (b) Kisfaludy, L.; Schön, I. Synthesis 1983, 325-326.
54. Roe, E. T.; Scanlan, J. T.; Swern, D. J. Am. Chem. Soc. 1949, 71, 2215-2218.
55. Crossley, R.; Curran, A. C. W.; Hill, D. G. J. Chem. Soc., Perkin Trans 1, 1976, 977-982.
56. Matsumoto, K.; Hashimoto, S.; Otani, S. Angew. Chem., Int. Ed. 1986, 25, 565-566.
57. Matsumoto, K.; Hashimoto, S.; Uchida, T.; Okamoto, T.; Otani, S. Chem. Ber. 1989, 122, 1357-1363.
58. For trimethylaluminum, see: Dolle, R. E.; Nicolaou, K. C. J. Am. Chem. Soc. 1985, 107, 1695-1698.
59. For bis[bis(trimethylsilyl)amido] tin(II), see: Wang, W.-B.; Roskamp, E. J. J. Org. Chem. 1992, 57, 6101-6103.
60. For lithium aluminum hydride, see: Evans, D. A. Tetrahedron Lett. 1969, 10, 1573-1576.
61. For sodium methoxide, see: (a) Achmatowicz, M.; Jurczak, J. Tetrahedron: Asymmetry 2001, 12, 111 -119.
62. (b) De Feo, R. J.; Strickler, P. D. J. Org. Chem. 1963, 28, 2915-2917.
63. For 2-hydroxypyridine, see: Openshaw, H. I.; Wittaker, N. J. Chem. Soc. C 1969, 89-91.
64. For sodium diethyldihydroaluminate, see: Sim, T. B.; Yoon, N. M. Synlett 1994, 10, 827-828.
65. For butyllithium, see: Yang, K.-W.; Cannon, J. G.; Rose, J. G. Tetrahedron Lett. 1970, 11, 1791-1794.
66. For methyl magnesium iodide, see: Houghton, R. P.; Williams, C. S. Tetrahedron Lett. 1967, 8, 3929-3931.
67. For sodium hydride, see: Singh, B. Tetrahedron Lett. 1971, 12, 321-322.
68. For potassium amide, see: Levi, E. M.; Mao, C.-L.; Hauser, C. R. Can. J. Chem. 1969, 47, 3761-3766.
69. For other miscellaneous methods, see: (a) Silicon tetrachloride. Chan, H.; Wong, L. T. L. J. Org. Chem. 1969, 34, 2766-2767.
70. (b) Sodium cyanide. Hogberg, T.; Strom, P.; Ebner, M.; Ramsby, S. J. Org. Chem. 1987, 52, 2033-2036.
71. (c) Enzymes. West, J. B.; Wong, C.-H. Tetrahedron Lett. 1987, 28, 1629-1632.
72. (d) Electrochemical method. Arai, K.; Shaw, C. H.; Nozawa, K.; Kawai, K.; Nakajima, S. Tetrahedron Lett. 1987, 28, 441-442.
73. Machetti, F.; Indiani, G.; Bucelli, I.; Guarna, A. C. R. Chim. 2003, 631-633.
74. For examples of aminolysis of methyl esters, see: (a) Labelle, M.; Gravel, D. Chem. Commun. 1985, 105-106.
75. (b) Rymbrandt, R. H.; Schmidt, F. L. J. Med. Chem. 1971, 14, 54-56.
76. (c) Chou, W.-C.; Tan, C.-W.; Chen, S.-F.; Ku, H. J. Org. Chem. 1998, 63, 10015-10017.
77. We choose p-nitrobenzo ester rather than other substituted benzoates because the rate of aminolysis of the substituted benzoates increases as the substituents change from a strong electron-donating group to a strong electron-withdrawing group, see: Um, I.-H.; Jeon, S.-E.; Seok, J.-A. Chem.-Eur. J. 2006, 12, 1237-1243.
78. Richard, J. P.; Toteva, M. M.; Crugeiras, J. J. Am. Chem. Soc. 2000, 122, 1664-1674.
79. For recents reviews, see: (a) De La Hoz, A.; Diaz-Ortiz, A.; Moreno, A. Chem. Soc. Rev. 2005, 34, 164-178.
80. (b) Kappe, C. O. Angew. Chem., Int. Ed. 2004, 43, 6250-6284.
81. (c) Hayes, B. L. Aldrichim. Acta 2004, 37, 66-77.
82. (d) Kappe, C. O.; Dallinger, D. Nat. Rev. Drug Discovery 2006, 5, 51-63.
83. (41 ) For tert-butoxide-mediated aminolysis, see: (a) Varma, R. S.; Naicker, K. P. S Tetrahedron Lett. 1999, 40, 6177-6180.
84. (b) Zradni, F.-Z.; Hamelin, J.; Derdour, A. Synth. Commun. 2002, 32, 3525-3531.
85. For aminolysis in the absence of base or induced by tenbutoxide, see: Perreux, L.; Loupy, A.; Delmotte, M. Tetrahedron 2003, 59, 2185-2189.
86. For technical reasons (minimum filling volume of the reaction vessel = 0.5 mL), it was not feasible to run those reactions under solvent-free conditions.